Anna Söderlund Strand
1 – 29 of 29
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
(
- Contribution to journal › Article
- 2023
-
Mark
Subclass-switched anti-Spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
(
- Contribution to journal › Article
- 2022
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(
- Contribution to journal › Article
- 2021
-
Mark
Intrauterine vertical SARS-CoV-2 infection : a case confirming transplacental transmission followed by divergence of the viral genome
(
- Contribution to journal › Article
-
Mark
HPV73 in cervical cancer and distribution of HPV73 variants in cervical dysplasia
(
- Contribution to journal › Article
-
Mark
Risk of environmental transmission of norovirus infection from prior room occupants
(
- Contribution to journal › Article
-
Mark
Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
(
- Contribution to journal › Article
-
Mark
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers : Population-based follow-up of a cluster-randomised trial
(
- Contribution to journal › Article
- 2020
-
Mark
A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcripts
(
- Contribution to journal › Article
-
Mark
Sources of Airborne Norovirus in Hospital Outbreaks
(
- Contribution to journal › Article
- 2019
-
Mark
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group : Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)
(
- Contribution to journal › Article
-
Mark
Airborne winter vomiting disease virus detected in particles <1 μm in hospital outbreaks
2019) European Aerosol Conference 2019(
- Contribution to conference › Abstract
- 2018
-
Mark
Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data
(
- Contribution to journal › Article
-
Mark
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females—Post-hoc analysis of a community-randomized clinical trial (II)
(
- Contribution to journal › Article
-
Mark
Risk factors for hospital norovirus outbreaks : impact of vomiting, genotype, and multi-occupancy rooms
(
- Contribution to journal › Article
- 2016
-
Mark
Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes
(
- Contribution to journal › Article
- 2015
-
Mark
Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
(
- Contribution to journal › Article
-
Mark
Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome.
(
- Contribution to journal › Article
- 2014
-
Mark
Change in Population Prevalences of Human Papillomavirus after Initiation of Vaccination: The High-Throughput HPV Monitoring Study.
2014) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology(
- Contribution to journal › Article
- 2013
-
Mark
High-Throughput Monitoring of Human Papillomavirus Type Distribution
(
- Contribution to journal › Article
-
Mark
Patterns of Human Papillomavirus Types in Multiple Infections: An Analysis in Women and Men of the High Throughput Human Papillomavirus Monitoring Study
(
- Contribution to journal › Article
-
Mark
Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.
(
- Contribution to journal › Article
-
Mark
Diversity of human papillomaviruses in skin lesions.
(
- Contribution to journal › Article
-
Mark
Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.
2013) In Journal of Medical Virology(
- Contribution to journal › Article
- 2011
-
Mark
Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
(
- Contribution to journal › Article
- 2009
-
Mark
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
(
- Contribution to journal › Article
- 2008
-
Mark
High throughput genotyping of oncogenic human papilloma viruses using MALDI-TOF mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Human papillomavirus testing and its application in cervical cancer prevention
(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
(
- Contribution to journal › Article